Tanezumab

Discussion in 'Pfizer' started by anonymous, Jun 1, 2020 at 1:26 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    When are we launching and what divisions? Are we still planning to co-promote with Lilly??
     

  2. anonymous

    anonymous Guest

    Troll
     
  3. anonymous

    anonymous Guest

    Drug will have horrible coverage and won’t have a chance. IM division is doomed. Never seen so many worthless reps still exist. Hopefully layoffs soon to get rid of so much baggage
     
  4. anonymous

    anonymous Guest

    Xeljanz needs it and will take anything to avoid the 60% layoffs coming as a result of stupid marketing decision to double the sales force 2yrs ago & not having a Renvoq plan 8 months ago which led them to kicking out butt .

    We need a product BAD as Inflectra is a worse dog than Eucrisa!
    Kinda sad 2 of 3 products in I&I are total dogs loosing money and Xeljanz has to cover the overhead and pay the bills for all 3 sales forces while crashing off the top of the mountain with a new Renvoq king of the hill.
     
  5. anonymous

    anonymous Guest

    WTF, you think you are special? You aren’t special! Most of who is left after years of layoffs are solid reps. It’s our bags that suck.